Shanghai Serum Bio-Technology Co. Ltd. A
医疗健康 · 生物科技
Shanghai Serum Bio-Technology Co., Ltd. engages in research, development, production, operation, and sales of antitoxin and antivenom serum products for biotoxins and biosafety in China. It offers equine anti-tetanus immunoglobulin, antivenom, and anti-rabies serum products. The company also engaged in the collection and sale of animal immune plasma. The company was founded in 1999 and is based in Shanghai, China.
MARKET 市值 4.40B CNY PE 88.4x
52W ¥19.93 – ¥52.88
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 5.7%
▲ ROE 4.4% 营业利润率 -6.0% 净利润率 24.6%
ANALYST 股息率 0.96%